仿T

Yuki Kagoya1

  • 1Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.

International immunology
|August 17, 2023
PubMed
概括

化学抗原受体 (CAR) -T细胞疗法对血液癌症有希望,但缺乏耐用性. 调节细胞因子信号的基因工程策略可以增强CAR-T细胞功能并减轻毒性,以改善癌症治疗.